Documents 2006 A.S.C.O. ANNUAL MEETING Atlanta (Georgia) - June 2-6, 2006

The triplet combination of irinotecan, oxaliplatin, and 5FU/LV (FOLFOXIRI) versus the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal…

Documents 2007 A.S.C.O. Annual Meeting Chicago (USA), June 1-5

Updated results, multivariate and subgroups analysis confirm improved activity and efficacy for FOLFOXIRI vs FOLFIRI in the G.O.N.O. randomized phase III study in metastatic…